Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × aflibercept × 30 days × Clear all

Sponsor

Conditions

Melanoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Gemcitabine 15 Specimen Handling 13 Magnetic Resonance Spectroscopy 12 pembrolizumab 11 Cisplatin 10 durvalumab 7 Nivolumab 6 Cystoscopy 6 Docetaxel 5 avelumab 4 atezolizumab 4 Transurethral Resection of Bladder 4 Radiotherapy 4 Radiation 4 Paclitaxel 4 Mitomycin 4 Carboplatin 4 Biopsy 4 erdafitinib 3 enfortumab vedotin 3 cabozantinib 3 Standard of Care 3 Ipilimumab 3 Immunoglobulin G 3 Fluorouracil 3 Disulfides 3 CTLA-4 Antigen 3 sacituzumab govitecan 2 eribulin 2 dehydroftorafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡